PRESS RELEASE | Basel, Switzerland, November 10, 2022

Versameb AG (“Versameb”), a pre-clinical stage company focused on discovering and developing innovative RNA-based therapeutics, is pleased to announce that its Chief Executive Officer, Klaas Zuideveld will be presenting on the Company’s proprietary mRNA engineering technology platform, VERSagile, at the LSX Inv€$tival Showcase Conference taking place on 14 November 2022 at Old Billingsgate in London, UK.